Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide

Paolo Angeli(University of Padua), Angelo Gatta(University of Padua), Piero Amodio(University of Padua), Paola Roner(University of Padua), Roberta Volpin(University of Padua), A. Sticca(University of Padua), Lorenza Caregaro(University of Padua), Roberto Merenda(University of Padua), A Maffei-Faccioli(University of Padua), Raffaella Craighero(University of Padua), Giorgio Enrico Gerunda(University of Modena and Reggio Emilia)
Hepatology
June 1, 1999
10.1002/hep.510290629
Cited by 560

Related Papers

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
Nutrition and survival in patients with liver cirrhosis
|Nutrition|2001|514
Limitations of Serum Creatinine Level and Creatinine Clearance as Filtration Markers in Cirrhosis
|Archives of Internal Medicine|1994|316
Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy
|Supportive Care in Cancer|2009|266
Malnutrition in alcoholic and virus-related cirrhosis
|American Journal of Clinical Nutrition|1996|266